Cover Image
市場調查報告書

美國關節鏡市場預測

United States Arthroscopy Market Outlook to 2020

出版商 GlobalData 商品編碼 296494
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
美國關節鏡市場預測 United States Arthroscopy Market Outlook to 2020
出版日期: 2014年02月14日 內容資訊: 英文 61 Pages
簡介

本報告提供美國關節鏡市場現狀與未來發展預測相關調查,提供市場規模(以金額·數量為準)的實際成果值·預測值,及市場價格趨勢,市場佔有率現況,再彙整主要企業的概要與策略,開發中的產品等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 美國的關節鏡市場

  • 收益(實際成果)
  • 收益(預測)
    • 各市場區隔
  • 數量(實際成果)
  • 數量(預測)
    • 各市場區隔
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • Arthrex, Inc.
  • Smith & Nephew Plc
  • ConMed Corporation
  • DePuy Companies
  • Stryker Corporation
  • ArthroCare Corporation
  • Biomet, Inc.

第5章 開發中產品

第6章 財務交易的展望

  • 私募股權
  • 創業融資

第7章 最近的趨勢

第8章 附錄

圖表一覽

目錄
Product Code: GDMECC0001DB

GlobalData's new report, "United States Arthroscopy Market Outlook to 2020", provides key market data on the United States Arthroscopy market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arthroscopy Implants, Arthroscopy Radio Frequency Wands, Arthroscopy Fluid Management Systems, Arthroscopes, Arthroscopic Shavers, Arthroscopy Radio Frequency Systems and Arthroscopy Visualization Systems.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Arthroscopy market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Arthroscopy Implants, Arthroscopy Radio Frequency Wands, Arthroscopy Fluid Management Systems, Arthroscopes, Arthroscopic Shavers, Arthroscopy Radio Frequency Systems and Arthroscopy Visualization Systems.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United States Arthroscopy market.
  • Key players covered include Arthrex, Inc., ConMed Corporation, Smith & Nephew Plc, DePuy Companies, Stryker Corporation, ArthroCare Corporation and Biomet, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Arthroscopy Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Arthroscopy Market, United States

  • 3.1. Arthroscopy Market, United States, Revenue ($m), 2005-2012
  • 3.2. Arthroscopy Market, United States, Revenue ($m), 2012-2020
    • 3.2.1. Arthroscopy Implants Market, United States, Revenue ($m), by Segment, 2005-2012
    • 3.2.2. Arthroscopy Implants Market, United States, Revenue ($m), by Segment, 2012-2020
  • 3.3. Arthroscopy Market, United States, Volume (Units), 2005-2012
  • 3.4. Arthroscopy Market, United States, Volume (Units), 2012-2020
    • 3.4.1. Arthroscopy Implants Market, United States, Volume (Units), by Segment, 2005-2012
    • 3.4.2. Arthroscopy Implants Market, United States, Volume (Units), by Segment, 2012-2020
  • 3.5. Arthroscopy Market, United States, Average Price ($), 2005-2020
  • 3.6. Arthroscopy Market, United States, Distribution Share by Revenue ($m), 2011-2012
  • 3.7. Arthroscopy Market, United States, Company Share by Revenue ($m), 2011-2012

4. Overview of Key Companies in United States Arthroscopy Market

  • 4.1. Arthrex, Inc.
    • 4.1.1. Company Overview
  • 4.2. Smith & Nephew Plc
    • 4.2.1. Company Overview
  • 4.3. ConMed Corporation
    • 4.3.1. Company Overview
  • 4.4. DePuy Companies
    • 4.4.1. Company Overview
  • 4.5. Stryker Corporation
    • 4.5.1. Company Overview
  • 4.6. ArthroCare Corporation
    • 4.6.1. Company Overview
  • 4.7. Biomet, Inc.
    • 4.7.1. Company Overview

5. Arthroscopy Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Private Equity
    • 6.1.1. Genstar Capital Acquires Tecomet From Charlesbank Capital Partners
  • 6.2. Venture Financing
    • 6.2.1. Medrobotics Raises US$21.3 Million In Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Sep 25, 2013: Accellent Announces the Promotion of Jeremy Friedman to President and Chief Operating Officer for the Cardio & Vascular Business and the Appointment of Richard Johnson as Interim CFO
    • 7.1.2. Aug 20, 2013: Pivot Medical Enlists Kevin Sidow to Serve on Its Board of Directors
    • 7.1.3. Jul 30, 2013: CONMED Corporation Adds Two New Board Members
    • 7.1.4. Jul 23, 2013: Dean Schauer, Executive Vice President, Cardio & Vascular Group, Announces Resignation
    • 7.1.5. Jan 31, 2013: Small Bone Innovations Announces Management Changes
  • 7.2. Financial Announcements
    • 7.2.1. Nov 07, 2013: Accellent Announces Third Quarter 2013 Results
    • 7.2.2. Oct 24, 2013: CONMED Announces Third Quarter 2013 Financial Results
    • 7.2.3. Sep 30, 2013: CONMED Corporation to Announce Third Quarter 2013 Financial Results on October 24, 2013
    • 7.2.4. Aug 27, 2013: CONMED Corporation Announces Quarterly Cash Dividend
    • 7.2.5. Aug 13, 2013: Accellent Announces Second Quarter 2013 Results
    • 7.2.6. Aug 06, 2013: Accellent Announces Timing of Second Quarter 2013 Earnings Release and Conference Call
    • 7.2.7. Jul 24, 2013: CONMED Announces Second Quarter 2013 Financial Results
    • 7.2.8. Jul 10, 2013: CONMED Corporation to Announce Second Quarter 2013 Financial Results on July 24, 2013
    • 7.2.9. May 14, 2013: Accellent Reports Revenue Of $120.8m In Q1 2013
    • 7.2.10. Apr 25, 2013: Conmed Reports Revenue Of $187m In Q1 2013
    • 7.2.11. Mar 27, 2013: Accellent Reports Revenue Of $498.6m In 2012
    • 7.2.12. Feb 14, 2013: Conmed Reports Revenue Of $725.1m In 2012
  • 7.3. Government and Public Interest
    • 7.3.1. Jan 08, 2014: CONMED to Present at the 16th Annual Needham Growth Conference
    • 7.3.2. Nov 15, 2013: CONMED to Participate in Two Investor Conferences
    • 7.3.3. Aug 29, 2013: CONMED to Present at CL King's 11th Annual Best Ideas Conference 2013
    • 7.3.4. Aug 06, 2013: CONMED to Present at The Wedbush 2013 Management Access Conference
  • 7.4. Legal And Regulatory
    • 7.4.1. Oct 09, 2013: KFx Medical Receives $29 Million Award and a Finding of Willful Infringement by Arthrex in Patent Infringement Case
  • 7.5. Other Significant Developments
    • 7.5.1. Jan 13, 2014: AUXILIO Signs Five-Year Managed Print Services Contract with University of California at San Diego (UCSD) Health System
    • 7.5.2. Oct 28, 2013: CONMED Increases Quarterly Cash Dividend by 33%
    • 7.5.3. Aug 12, 2013: Small Bone Innovations Launches New Charcot Solution Website
    • 7.5.4. May 24, 2013: CONMED Announces Quarterly Cash Dividend
    • 7.5.5. Feb 27, 2013: CONMED Announces Quarterly Cash Dividend

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Arthroscopy Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 2: Arthroscopy Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 3: Arthroscopy Implants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 4: Arthroscopy Implants Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 5: Arthroscopy Market, United States, Volume (Units), Historic, 2005-2012
  • Table 6: Arthroscopy Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 7: Arthroscopy Implants Market, United States, Volume (Units), Historic, 2005-2012
  • Table 8: Arthroscopy Implants Market, United States, Volume (Units), Forecast, 2012-2020
  • Table 9: Arthroscopy Market, United States, Average Price ($), Historic, 2005-2012
  • Table 10: Arthroscopy Market, United States, Average Price ($), Forecast, 2012-2020
  • Table 11: Arthroscopy Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 12: Arthroscopy Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 13: Arthroscopy Market Pipeline Products
  • Table 14: Genstar Capital Acquires Tecomet From Charlesbank Capital Partners
  • Table 15: Medrobotics Raises US$21.3 Million In Venture Financing
  • Table 16: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Arthroscopy Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 2: Arthroscopy Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 3: Arthroscopy Implants Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 4: Arthroscopy Implants Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 5: Arthroscopy Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 6: Arthroscopy Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 7: Arthroscopy Implants Market, United States, Volume (Units), Historic, 2005-2012
  • Figure 8: Arthroscopy Implants Market, United States, Volume (Units), Forecast, 2012-2020
  • Figure 9: Arthroscopy Market, United States, Company Share (%), 2012
  • Figure 10: GlobalData Epidemiology-Based Forecasting Model
  • Figure 11: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 12: Primary Interviews by Participant Type (%)
Back to Top